IO Biotech Inc (IOBT) — Net Asset Quality Index
IO Biotech Inc (IOBT) has a Net Asset Quality Index of 2.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $39.96 Million minus total liabilities of $39.05 Million yields net assets of $911.00K. A higher index indicates a stronger, lower-leverage balance sheet. Read IOBT total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
IO Biotech Inc Net Asset Quality Index Over Time (2019–2024)
This chart shows how IO Biotech Inc's Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the index stands at 2.3%, representing net assets of $911.00K against total assets of $39.96 Million USD. For live market cap and overall valuation, see IOBT market cap.
Annual Net Asset Quality Index for IO Biotech Inc (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for IO Biotech Inc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check IO Biotech Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.4% | $47.02 Million | $67.70 Million | $20.68 Million | ▼ -18.9 pp |
| 2023 | 88.4% | $133.16 Million | $150.72 Million | $17.56 Million | ▼ -3.1 pp |
| 2022 | 91.5% | $138.85 Million | $151.81 Million | $12.95 Million | ▼ -3.9 pp |
| 2021 | 95.3% | $211.92 Million | $222.29 Million | $10.36 Million | ▲ +49.3 pp |
| 2020 | 46.0% | $2.60 Million | $5.65 Million | $3.05 Million | ▲ +61.7 pp |
| 2019 | -15.6% | $-1.47 Million | $9.42 Million | $10.89 Million | — |